trial
as of 2026-07-01Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
NCTId NCT02212613
at a glance
Phase 3 · Withdrawn
Enrollment 0 (actual)
Primary completion 2015-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
Single
Start
2014-09
Primary completion
2015-11
Eligibility
ALL · 18 Years · 55 Years
Interventions & indications
Sponsors
Investigators
1
Jun-ichi Hashimoto, PhDStudy Director
Sites
1 total
Atlanta, United States
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
0
Phase
PHASE3
Primary Completion Date
2015-11
Status
WITHDRAWN
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person